VERU
VERU
NASDAQ · Pharmaceuticals

Veru Inc

$2.12
+0.06 (+2.91%)
As of Nov 7, 2:40 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,667.9% upside
Low Target $21.76
Average Target $37.48
High Target $51.92
Current Price $2.12
Current
$2.12
Target
$37.48
$21.76 $37.48 avg $51.92
Scenario Analysis
Bear Case
$21.76
926.4%
Low target
Base Case
$37.48
+1,667.9%
Avg target
Bull Case
$51.92
+2,349.1%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.33
-71.1% from high
52-Week Low
$2.04
+3.9% from low
Target vs 52W High
$37.48
+411.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%